T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
1976
DELISTED
Meridian Bioscience Inc
VIVO
| $812K | ﹤0.01% |
26,679
-8,931
| -25% | -$242K |
|
1977
Cerence
CRNC
$391M
| $811K | ﹤0.01% |
32,147
+2,082
| +7% | +$62.3K |
|
|
VGR
1978
DELISTED
Vector Group Ltd.
VGR
| $810K | ﹤0.01% |
77,181
+3,834
| +5% | +$46.1K |
|
1979
BioCryst Pharmaceuticals
BCRX
$2.71B
| $806K | ﹤0.01% |
76,146
-4,863
| -6% | -$50.2K |
|
1980
Integer Holdings
ITGR
$4.25B
| $805K | ﹤0.01% |
11,394
-1,291
| -10% | -$98.6K |
|
1981
StoneX
SNEX
$8.37B
| $805K | ﹤0.01% |
52,225
+623
| +1% | +$9K |
|
1982
NETSCOUT
NTCT
$2.87B
| $804K | ﹤0.01% |
23,760
+1,426
| +6% | +$47.8K |
|
1983
Tootsie Roll Industries
TR
$3.05B
| $802K | ﹤0.01% |
25,522
-15
| -0.1% | -$453 |
|
1984
Provident Financial Services
PFS
$3.24B
| $800K | ﹤0.01% |
35,947
+430
| +1% | +$9.61K |
|
1985
RE/MAX Holdings
RMAX
$263M
| $799K | ﹤0.01% |
32,590
+154
| +0.5% | +$3.74K |
|
1986
Kforce
KFRC
$1.03B
| $798K | ﹤0.01% |
13,005
+6,373
| +96% | +$435K |
|
|
VRE
1987
DELISTED
Veris Residential
VRE
| $798K | ﹤0.01% |
60,251
-1,856
| -3% | -$28.7K |
|
1988
Shenandoah Telecom
SHEN
$721M
| $796K | ﹤0.01% |
35,846
+347
| +1% | +$7.84K |
|
1989
CVR Energy
CVI
$3.52B
| $795K | ﹤0.01% |
23,734
-13,231
| -36% | -$422K |
|
1990
3D Systems Corp
DDD
$603M
| $795K | ﹤0.01% |
81,982
-5,976
| -7% | -$69.8K |
|
1991
CarGurus
CARG
$3.29B
| $794K | ﹤0.01% |
36,939
+3,117
| +9% | +$92.2K |
|
1992
Forrester Research
FORR
$220M
| $794K | ﹤0.01% |
16,598
+614
| +4% | +$31.8K |
|
|
POLY
1993
PUT
DELISTED
Plantronics, Inc.
POLY
| $794K | ﹤0.01% |
+20,000
| New | +$794K |
|
1994
Dana Inc
DAN
$3.2B
| $792K | ﹤0.01% |
56,317
-702
| -1% | -$10.9K |
|
|
FFIC
1995
DELISTED
Flushing Financial
FFIC
| $792K | ﹤0.01% |
37,240
+132
| +0.4% | +$2.9K |
|
|
VRTV
1996
DELISTED
VERITIV CORPORATION
VRTV
| $792K | ﹤0.01% |
7,296
+830
| +13% | +$113K |
|
1997
Kennametal
KMT
$2.35B
| $787K | ﹤0.01% |
33,888
+420
| +1% | +$11.1K |
|
1998
Dave & Buster's
PLAY
$361M
| $787K | ﹤0.01% |
23,997
+233
| +1% | +$9.34K |
|
|
NXGN
1999
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $786K | ﹤0.01% |
45,055
-8,284
| -16% | -$158K |
|
2000
Brinker International
EAT
$10.5B
| $782K | ﹤0.01% |
35,501
+1,439
| +4% | +$45.5K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.